Steven Severyn

Steven Severyn, MD

  • Anesthesiology
  • Anesthesiology Pain Management

Appointments cannot be scheduled directly with this provider. (614) 293-2225

Specialties and conditions I treat

  • Anesthesiology
  • Anesthesiology Pain Management
  • Spinal Diseases
  • Anesthesia
  • Referral and Consultation
  • Pain Management
  • Chronic Pain

Education and training

Medical Degree

M.D.
Ohio State University College of Medicine
6/13/1980

Residency

General Medicine
Riverside Methodist Hospital
7/1/1980 - 6/30/1983

More about my work

My background

Fellowship

Pain Management
Ohio State University Wexner Medical Center
8/1/2000 - 7/30/2001

Board Certifications

American Board of Anesthesiology
4/23/1993

American Board of Anesthesiology (Subspecialty: Pain Management)
9/15/2001

American Board of Internal Medicine
9/11/1985

My Department

Anesthesiology

Reviews

92 Patient Satisfaction Reviews

The patient satisfaction rating is an average of all responses to the six doctor communication related questions shown below from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page
  • Overall
    4.6 out of 5
  • Explains Things Clearly 4.6
  • Listens Carefully 4.7
  • Gives Understandable Instructions 4.6
  • Knows My Medical History 4.7
  • Shows Respect 4.7
  • Time Spent Together 4.6

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 03/28/2017, Dr. Severyn has reported no financial relationships with medical device, research and/or drug companies.